Phase 2 Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing and able to sign a consent form before the study begins
- You must be 18 years old or older
- You must be scheduled for planned (non-emergency) heart surgery using a heart-lung bypass machine, and your surgery must be one of the following types: heart valve surgery, coronary artery bypass surgery (CABG), a combination of valve and bypass surgery, multiple valve surgeries, other combined heart procedures, or surgery on the aorta (the main artery from the heart)
- In addition to the surgery type, you must also have at least one of the following risk factors: a predicted surgical risk of death of 8% or higher (based on a scoring tool called EuroSCORE II), be aged 70 or older, have a frailty score of 4 or above on a standard frailty scale, need surgery urgently within 24–48 hours of being admitted to hospital, or have a weakened heart that pumps less than 35% of its normal capacity
Who may not be able to join:
- You have a known allergy to fish, fish oil, or egg protein
- You are pregnant or currently breastfeeding
- You have a history of long-term irregular heart rhythms such as atrial fibrillation, atrial flutter, or related conditions
- You are unwilling or unable to sign a consent form
- You are not expected to survive more than 48 hours from the time of assessment
- There are plans to limit or withdraw your medical treatment within the first week (though a "do not resuscitate" order alone does not exclude you)
- You have been admitted with a serious diabetic crisis (such as diabetic ketoacidosis or a related condition)
- You are currently using a mechanical heart support device or receiving advanced heart failure treatments
- You have taken part in another interventional clinical trial within the last 30 days
- You are already receiving medical nutrition products that contain fish oil
- You are severely underweight, with a body mass index (BMI) below 18.5
- You have severe liver disease (classified as Child Pugh Class C) (confirm with trial site)
- You have severe long-term kidney disease, with kidney function measured at less than 30 ml/min
- You have a known severe disorder affecting your blood's ability to clot
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christian Stoppe, Prof. Dr., Wuerzburg University Hospital
Phone: 49-931-20130001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Atrial fibrillation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.